[go: up one dir, main page]

Kaplan et al., 2010 - Google Patents

The bradykinin-forming cascade and its role in hereditary angioedema

Kaplan et al., 2010

Document ID
12324344529700967518
Author
Kaplan A
Joseph K
Publication year
Publication venue
Annals of Allergy, Asthma & Immunology

External Links

Snippet

OBJECTIVE: To review the mechanisms by which bradykinin is generated in hereditary angioedema (HAE)(C1 inhibitor deficiency), including the role of human plasma proteins and endothelial cells. DATA SOURCES: Published articles in reviewed journals that address …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813Exopeptidases (3.4.11. to 3.4.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)

Similar Documents

Publication Publication Date Title
Kaplan et al. The bradykinin-forming cascade and its role in hereditary angioedema
Kaplan et al. The plasma bradykinin-forming pathways and its interrelationships with complement
AU666854B2 (en) ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
Bernkop-Schnürch The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins
Sala et al. A functional assay of protein C in human plasma
Lin et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro
Sherry et al. Proteolytic enzymes: a therapeutic evaluation
JP2003514790A (en) Method for thrombolysis by local delivery of reversibly inactivated acidified plasmin
Ishii et al. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells
KR20140033010A (en) Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor
JPH06184196A (en) Peptides derived from vitronectin and medicinal compositionscontaining them
BR112014004297B1 (en) USE OF AN ANTITHROMBIN III INHIBITOR IN THE TREATMENT OR PREVENTION OF BLEEDING
Råanby et al. Biological control of tissue plasminogen activator-mediated fibrinolysis
Seitz et al. Prothrombin activation by thrombolytic agents
Stenman Tumour-associated trypsin inhibitor and tumour-associated trypsin
Pechet et al. The effect of certain proteolytic enzymes on the thrombin-fibrinogen interaction
Desmazes et al. Cathepsin L, but not cathepsin B, is a potential kininogenase
Coleman et al. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone
NZ515063A (en) A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor
Kaplan Kinins, airway obstruction, and anaphylaxis
Lombardi et al. Imbalance between Plasminogen Activator and its Inhibitors in Thiol-Lnduced Acantholysis
Frank Hereditary angio-oedema
Patrassi et al. The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril
AU2003213856B2 (en) Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy
Jacobsen The antiplasmin activity of human plasma and serum and its dependence on ions